P0C195 (CM3A_CONKI) Conus kinoshitai (Kinoshita's cone)

Mu-conotoxin KIIIB UniProtKBInterproInteractive Modelling

22 aa; Sequence (Fasta)

Sequence Features

 11Key residue in the pharmacophore, alpha- helical region.
 12Key residue in the pharmacophore, alpha- helical region.
 14Key residue in the pharmacophore, alpha- helical region.
 15Key residue in the pharmacophore, alpha- helical region.
 16Key residue in the pharmacophore, alpha- helical region.
 18Key residue in the pharmacophore.
 5-20in KIIIA-P2 and KIIIB-P1; alternate.
 5-19in KIIIA-P1 and KIIIB-P2; alternate.
 6-13in KIIIA-P1, KIIIA-P2, KIIIB-P1 and KIIIB-P2.
 8-20in KIIIA-P1 and KIIIB-P2; alternate.
 8-19in KIIIA-P2 and KIIIB-P1; alternate.

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Human Nav1.2-beta2-KIIIA ternary complex Heteromer
O60939; Q99250;
9Z9;BMA;NAG;NA;6j8e5-20
NMR solution structure of Mu-conotoxin KIIIAmonomer 2lxg5-20